Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations
1 clinical trials · Condition
◉ Watch Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations
| Record | Firm | Date |
|---|---|---|
| Basket Study of Neratinib in Participants With Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations (NCT01953926) | Puma Biotechnology, Inc. | 2013-09-30 |
Track Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations automatically
Every clearance here is in the API, with alerts when new ones post.